Arcadia Biosciences (RKDA) Receives a Buy from National Securities Corp

In a report released today, Ben Klieve from National Securities Corp reiterated a Buy rating on Arcadia Biosciences (RKDA), with a price target of $16.00. The company’s shares closed last Monday at $3.31.

According to, Klieve is a 1-star analyst with an average return of -7.4% and a 35.2% success rate. Klieve covers the Consumer Goods sector, focusing on stocks such as AgroFresh Solutions, Yield10 Bioscience, and S&W Seed Company.

Currently, the analyst consensus on Arcadia Biosciences is a Moderate Buy with an average price target of $16.00.

See today’s analyst top recommended stocks >>

Based on Arcadia Biosciences’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $392K and GAAP net loss of $14.19 million. In comparison, last year the company earned revenue of $370K and had a net profit of $4.45 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. The company’s portfolio of agricultural productivity traits includes Nitrogen Use Efficiency, Water Use Efficiency, Drought Tolerance, Salinity Tolerance and Herbicide Tolerance. It has presence in the United States, Africa, India, the United Arab Emirates, Belgium, France and Canada. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts